Adamis Pharmaceuticals Corp (ADMP):企業の財務・戦略的SWOT分析

◆英語タイトル:Adamis Pharmaceuticals Corp (ADMP) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH140821FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Adamis Pharmaceuticals Corp (Adamis) formerly Cellegy Pharmaceuticals Inc, is a bio pharmaceutical company that develops therapies in areas of respiratory disease and allergy. The company offers pipeline product, epinephrine pre-filled syringe is developed for anaphylactic reactions such as insect stings, foods, medications and latex. It also offers pipeline products such as APC-2000 for the treatment of bronchospasms; APC-1000 and APC-4000 for the treatment of asthma and chronic obstructive pulmonary disease; and steroid product for the treatment of allergic rhinitis. Adamis is headquartered in San Diego, California, the US

Adamis Pharmaceuticals Corp Key Recent Developments

Jan 26,2021: Adamis Pharmaceuticals provides update on its us compounding business
Nov 09,2020: Adamis Pharmaceuticals announces third quarter 2020 financial results and business update
Aug 17,2020: Adamis Pharmaceuticals announces second quarter 2020 financial results and business update
May 18,2020: Adamis Pharmaceuticals announces first quarter 2020 financial results and business update
May 11,2020: Adamis Pharmaceuticals provides update on SYMJEPI products and announces distribution and commercialization agreement for SYMJEPI and ZIMHI products

This comprehensive SWOT profile of Adamis Pharmaceuticals Corp provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Adamis Pharmaceuticals Corp including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Adamis Pharmaceuticals Corp – Key Information
Adamis Pharmaceuticals Corp – Overview
Adamis Pharmaceuticals Corp – Key Employees
Adamis Pharmaceuticals Corp – Key Employee Biographies
Adamis Pharmaceuticals Corp – Key Operational Heads
Adamis Pharmaceuticals Corp – Major Products and Services
Adamis Pharmaceuticals Corp – History
Adamis Pharmaceuticals Corp – Company Statement
Adamis Pharmaceuticals Corp – Locations And Subsidiaries
Adamis Pharmaceuticals Corp
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Adamis Pharmaceuticals Corp – Business Description
Adamis Pharmaceuticals Corp – Corporate Strategy
Adamis Pharmaceuticals Corp – SWOT Analysis
SWOT Analysis – Overview
Adamis Pharmaceuticals Corp – Strengths
Adamis Pharmaceuticals Corp – Weaknesses
Adamis Pharmaceuticals Corp – Opportunities
Adamis Pharmaceuticals Corp – Threats
Adamis Pharmaceuticals Corp – Key Competitors

Section 3 – Company Financial Performance Charts

Adamis Pharmaceuticals Corp – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Adamis Pharmaceuticals Corp, Key Information
Adamis Pharmaceuticals Corp, Key Ratios
Adamis Pharmaceuticals Corp, Share Data
Adamis Pharmaceuticals Corp, Major Products and Services
Adamis Pharmaceuticals Corp, History
Adamis Pharmaceuticals Corp, Key Employees
Adamis Pharmaceuticals Corp, Key Employee Biographies
Adamis Pharmaceuticals Corp, Key Operational Heads
Adamis Pharmaceuticals Corp, Other Locations
Adamis Pharmaceuticals Corp, Subsidiaries
Adamis Pharmaceuticals Corp, Key Competitors
Adamis Pharmaceuticals Corp, SWOT Analysis
Adamis Pharmaceuticals Corp, Ratios based on current share price
Adamis Pharmaceuticals Corp, Annual Ratios
Adamis Pharmaceuticals Corp, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Adamis Pharmaceuticals Corp (ADMP):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Halma Plc (HLMA):医療機器:M&Aディール及び事業提携情報
    Summary Halma Plc (Halma) develops, produces and sells life protection products to enhance personal and public health. The company’s product portfolio comprises fire detection and suppression systems, corrosion monitoring systems, gas detectors, elevator safety products, water treatment systems, aut …
  • Enel Generacion Chile SA:発電所・企業SWOT分析
    Enel Generacion Chile SA - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • Kurabo Industries Ltd (3106):企業の財務・戦略的SWOT分析
    Kurabo Industries Ltd (3106) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Grand Gulf Energy Ltd (GGE):石油・ガス:M&Aディール及び事業提携情報
    Summary Grand Gulf Energy Ltd (Grand Gulf Energy), formerly Alto Energy International Ltd, is an oil and gas exploration and production company. The company acquires, explores and develops conventional oil and gas assets in the US oil and gas basins. It holds interests in Napoleonville Salt Dome pro …
  • SDN Company Ltd (099220):電力:M&Aディール及び事業提携情報
    Summary SDN Company Ltd (SDN Company), formerly Seoul Marine Co Ltd is a diversified company that operates through its business divisions such as photovoltaic, engine, and shipbuilding divisions. The company’s photovoltaic business division manufactures solar inverters, solar panels, solar trackers, …
  • Energias de Portugal SA (EDP):石油・ガス:M&Aディール及び事業提携情報
    Summary Energias de Portugal, S.A. (EDP) is a vertically integrated power and gas utility that generates, transmits, distributes and sells electricity; and transports, distributes and sells natural gas. It produces electricity through a diversified portfolio of generation assets including wind, sola …
  • Waste Management, Inc. (WM):電力:M&Aディール及び事業提携情報
    Summary Waste Management, Inc. (WM) is a provider of waste management environmental services. The company has a presence in waste management vertical from collection, solid and hazardous waste landfills management, transfer, recycling and resource recovery, to disposal. It also develops, operates, a …
  • Logicalis Group Ltd:企業の戦略的SWOT分析
    Logicalis Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Glaukos Corp (GKOS):企業の製品パイプライン分析2018
    Summary Glaukos Corp (Glaukos) is an ophthalmic medical device company that research and develops micro technologies to improve glaucoma therapy. The company develops injectable micro-scale therapies to address the complete range of glaucoma disease states and progression. It provides products such …
  • Biosilu Healthcare AG (1YA)-製薬・医療分野:企業M&A・提携分析
    Summary Biosilu Healthcare AG (Biosilu Healthcare), formerly Amp Biosimilars AG is a life science company that develops and commercializes biopharmaceuticals. The company's product pipeline comprises biosimilar development projects on immune disorders and cancer. It offers products in therapeutic ar …
  • Cocrystal Pharma Inc (COCP):企業の財務・戦略的SWOT分析
    Summary Cocrystal Pharma Inc (Cocrystal Pharma), formerly Biozone Pharmaceuticals Inc, a subsidiary of MusclePharm Corp, is a clinical stage biotechnology company that discovers and develops novel antiviral therapeutics. The company provides treatments for chronic viral diseases. Its pipeline produc …
  • Carnival Corporation & plc:企業の戦略・SWOT・財務情報
    Carnival Corporation & plc - Strategy, SWOT and Corporate Finance Report Summary Carnival Corporation & plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Tokuyama Corporation (4043)-エネルギー分野:企業M&A・提携分析
    Summary Tokuyama Corporation (Tokuyama), formerly Nihon Soda Kogyo Co., Ltd., manufactures and sells chemicals, specialty products and cement. Its product portfolio includes soda ash, caustic soda, silicon products, vinyl chloride monomer/polymer, fine chemicals, film products, medical materials, me …
  • Cantargia AB (CANTA):企業の財務・戦略的SWOT分析
    Summary Cantargia AB (Cantargia), a subsidiary of Lund University Bioscience AB is a biotechnology company that develops antibody based cancer treatments. The company’s product candidate CAN04 is used for the treatment of cancers including non-small cell lung cancer and pancreatic cancer. It utilize …
  • Crinetics Pharmaceuticals Inc (CRNX):製薬・医療:M&Aディール及び事業提携情報
    Summary Crinetics Pharmaceuticals Inc (Crinetics) is a developer of novel therapeutics targeting peptide hormone receptors for the treatment of rare endocrine disorders and endocrine-related cancers. The company’s products include neuropeptides and their receptors, orally-available somatostatin agon …
  • First Light Biosciences Inc:製品パイプライン分析
    Summary First Light Biosciences Inc (FLB) is a medical device company that develops and manufactures automated medical diagnostic products for detection of healthcare associated infections. The company’s product include multipath analyzer. Its multipath analyzer detects resistant and sensitive staph …
  • Northern Vertex Mining Corp:企業の戦略・SWOT・財務分析
    Northern Vertex Mining Corp - Strategy, SWOT and Corporate Finance Report Summary Northern Vertex Mining Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Servair:企業の戦略・SWOT・財務分析
    Servair - Strategy, SWOT and Corporate Finance Report Summary Servair - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Calpine Corporation (CPN)-エネルギー分野:企業M&A・提携分析
    Summary Calpine Corporation (Calpine) is an electric and natural gas utility. The company produces electricity and thermal energy from natural gas, geothermal, and solar sources. It uses natural gas-fired combustion and renewable geothermal conventional steam turbine technologies to generate energy. …
  • PG&E Corp (PCG):企業の財務・戦略的SWOT分析
    PG&E Corp (PCG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆